Your browser doesn't support javascript.
loading
Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma.
Slater, K; Hoo, P S; Buckley, A M; Piulats, J M; Villanueva, A; Portela, A; Kennedy, B N.
Affiliation
  • Slater K; UCD School of Biomolecular & Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D04 V1W8, Ireland.
  • Hoo PS; Genomics Medicine Ireland Limited, Cherrywood Business Park Building 4, Dublin, D18 K7W4, Ireland.
  • Buckley AM; UCD School of Biomolecular & Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D04 V1W8, Ireland.
  • Piulats JM; Department of Surgery, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, Dublin, Ireland.
  • Villanueva A; Department of Surgery, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, Dublin, Ireland.
  • Portela A; Department of Medical Oncology, Catalan Institute of Oncology - IDIBELL - CIBERONC, Barcelona, Spain.
  • Kennedy BN; Xenopat S.L., Barcelona, Spain.
Cancer Metastasis Rev ; 37(2-3): 335-345, 2018 09.
Article in En | MEDLINE | ID: mdl-30094568
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Oncogene Proteins / Receptors, Leukotriene / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Metastasis Rev Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Oncogene Proteins / Receptors, Leukotriene / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Metastasis Rev Year: 2018 Document type: Article